Similarly, the observed cardioprotective effect of AMPK against pressure-overload-induced ventricular hypertrophy and dysfunction [16] can also be attributed in part to the AMPK-induced β-adrenergic pathway down-regulation. The gene discussed is PRKAA1; the disease is Ventricular hypertrophy.